![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Molecular Pharmacology, Vol 17, 86-94, Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics
1 McArdle Laboratoty for Cancer Research, University of Wisconsin, Madison, Wisconsin 53706
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related halogenated aromatic hydrocarbons (a) produce a similar pattern of toxic responses; (b) induce a battery of enzymes,
including aryl hydrocarbon hydroxylase (AHH) activity; and (c) bind reversibly and with
a high affinity to a cytosol protein that is the receptor for this enzyme induction response.
To test the hypothesis that the toxic effects produced by these compounds are mediated
by their binding to the induction receptor, we examined the genetic segregation of two
toxic responses, with the Ah locus, which determines this receptor. The dose-response
relationship for thymic atrophy produced by TCDD was examined in C57BL/6J mice,
which have a high affinity receptor and are sensitive to enzyme induction, DBA/2J mice,
which have a lower affinity receptor and are less sensitive to induction of AHH activity,
and hybrid B6D2F1/J mice. C57BL/6J mice were approximately 10-fold more sensitive
to thymic involution than DBA/2J mice and the hybrid B6D2F1/J were intermediate
between the two parental strains. The progeny of a B6D2F1/J x DBA/2J mating were
phenotyped (as Aa or aa), and the mice heterozygous for the high affinity receptor were
more sensitive to thymic atrophy. The capacity of other halogenated aromatic hydrocarbons to produce thymic atrophy corresponded to their capacity to bind to the induction
receptor, and nonhalogenated compounds which are agonists for the receptor (3-methylcholanthrene, 
-naphthoflavone) also produced this toxic response. TCDD produced a
dose-related incidence of cleft palate formation in the fetuses of C57BL/6J mice. A single
dose of 30 µg/kg of TCDD on day 10 of pregnancy produced an incidence of cleft palates
of 54% in C57BL/6J fetuses, 13% in B6D2F1/J fetuses and only 2% in DBA/2J fetuses.
Five inbred strains of mice with a low affinity receptor developed only a 0-3% incidence
of cleft palates from TCDD (30 µg/kg), while four of five inbred strains with a high
affinity receptor developed a 50% or greater incidence. For TCDD and congeners, (a) the
correspondence of the structure-activity relationship for receptor binding and for toxic
potency and (b) the segregation of thymic involution and probably teratogenesis with the
Ah locus indicate that binding of these compounds to the receptor is an essential step in
their mechanism of toxicity.
This article has been cited by other articles:
|
|
 |
|
  E. Sonneveld, A. Jonas, O. C. Meijer, A. Brouwer, and B. van der Burg Glucocorticoid-Enhanced Expression of Dioxin Target Genes through Regulation of the Rat Aryl Hydrocarbon Receptor Toxicol. Sci., October 1, 2007; 99(2): 455 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Okey An Aryl Hydrocarbon Receptor Odyssey to the Shores of Toxicology: The Deichmann Lecture, International Congress of Toxicology-XI Toxicol. Sci., July 1, 2007; 98(1): 5 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Bohonowych and M. S. Denison Persistent Binding of Ligands to the Aryl Hydrocarbon Receptor Toxicol. Sci., July 1, 2007; 98(1): 99 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. McMillan, S. N. McMillan, E. Glover, and C. A. Bradfield 2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Premature Activation of the KLF2 Regulon during Thymocyte Development J. Biol. Chem., April 27, 2007; 282(17): 12590 - 12597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Bemis, N. F. Alejandro, D. A. Nazarenko, A. I. Brooks, R. B. Baggs, and T. A. Gasiewicz TCDD-Induced Alterations in Gene Expression Profiles of the Developing Mouse Paw Do Not Influence Morphological Differentiation of This Potential Target Tissue Toxicol. Sci., January 1, 2007; 95(1): 240 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Thomae, E. A. Stevens, A. L. Liss, N. R. Drinkwater, and C. A. Bradfield The Teratogenic Sensitivity to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Is Modified by a Locus on Mouse Chromosome 3 Mol. Pharmacol., March 1, 2006; 69(3): 770 - 775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Walisser, E. Glover, K. Pande, A. L. Liss, and C. A. Bradfield Aryl hydrocarbon receptor-dependent liver development and hepatotoxicity are mediated by different cell types PNAS, December 6, 2005; 102(49): 17858 - 17863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Pande, S. M. Moran, and C. A. Bradfield Aspects of Dioxin Toxicity Are Mediated by Interleukin 1-Like Cytokines Mol. Pharmacol., May 1, 2005; 67(5): 1393 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Thomae, E. A. Stevens, and C. A. Bradfield Transforming Growth Factor-{beta}3 Restores Fusion in Palatal Shelves Exposed to 2,3,7,8-Tetrachlorodibenzo-p-dioxin J. Biol. Chem., April 1, 2005; 280(13): 12742 - 12746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Walisser, M. K. Bunger, E. Glover, and C. A. Bradfield Gestational exposure of Ahr and Arnt hypomorphs to dioxin rescues vascular development PNAS, November 23, 2004; 101(47): 16677 - 16682. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Thomae, E. Glover, and C. A. Bradfield A Maternal Ahr Null Genotype Sensitizes Embryos to Chemical Teratogenesis J. Biol. Chem., July 16, 2004; 279(29): 30189 - 30194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Walisser, M. K. Bunger, E. Glover, E. B. Harstad, and C. A. Bradfield Patent Ductus Venosus and Dioxin Resistance in Mice Harboring a Hypomorphic Arnt Allele J. Biol. Chem., April 16, 2004; 279(16): 16326 - 16331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Bunger, S. M. Moran, E. Glover, T. L. Thomae, G. P. Lahvis, B. C. Lin, and C. A. Bradfield Resistance to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Toxicity and Abnormal Liver Development in Mice Carrying a Mutation in the Nuclear Localization Sequence of the Aryl Hydrocarbon Receptor J. Biol. Chem., May 9, 2003; 278(20): 17767 - 17774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. Robinson, B. Clothier, R. A. Akhtar, A. L. Yang, I. Latour, C. Van Ijperen, M. F. W. Festing, and A. G. Smith Non-Ahr Gene Susceptibility Loci for Porphyria and Liver Injury Induced by the Interaction of `Dioxin' with Iron Overload in Mice Mol. Pharmacol., March 1, 2002; 61(3): 674 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Loaiza-Perez, V. Trapani, C. Hose, S. S. Singh, J. B. Trepel, M. F. G. Stevens, T. D. Bradshaw, and E. A. Sausville Aryl Hydrocarbon Receptor Mediates Sensitivity of MCF-7 Breast Cancer Cells to Antitumor Agent 2-(4-Amino-3-methylphenyl) Benzothiazole Mol. Pharmacol., January 1, 2002; 61(1): 13 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Thomas, D. R. Rank, S. G. Penn, G. M. Zastrow, K. R. Hayes, K. Pande, E. Glover, T. Silander, M. W. Craven, J. K. Reddy, et al. Identification of toxicologically predictive gene sets using cDNA microarrays Mol. Pharmacol., December 1, 2001; 60(6): 1189 - 1194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Schlezinger and J. J. Stegeman Dose and Inducer-Dependent Induction of Cytochrome P450 1A in Endothelia of the Eel, including in the Swimbladder Rete Mirabile, a Model Microvascular Structure Drug Metab. Dispos., June 1, 2000; 28(6): 701 - 708. [Abstract] [Full Text]
|
|
|
|
|
|
Q. Ma, A. J. Renzelli, K. T. Baldwin, and J. M. Antonini Superinduction of CYP1A1 Gene Expression. REGULATION OF 2,3,7,8-TETRACHLORODIBENZO-p-DIOXIN-INDUCED DEGRADATION OF Ah RECEPTOR BY CYCLOHEXIMIDE J. Biol. Chem., April 21, 2000; 275(17): 12676 - 12683. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Regulations and Advisories Toxicology and Industrial Health, April 1, 2000; 16(3-5): 173 - 201. [PDF]
|
|
|
|
|
|
Q. Ma and K. T. Baldwin 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced Degradation of Aryl Hydrocarbon Receptor (AhR) by the Ubiquitin-Proteasome Pathway. ROLE OF THE TRANSCRIPTION ACTIVATON AND DNA BINDING OF AhR J. Biol. Chem., March 17, 2000; 275(12): 8432 - 8438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Schlezinger, R. D. White, and J. J. Stegeman Oxidative Inactivation of Cytochrome P-450 1A (CYP1A) Stimulated by 3,3',4,4'-Tetrachlorobiphenyl: Production of Reactive Oxygen by Vertebrate CYP1As Mol. Pharmacol., September 1, 1999; 56(3): 588 - 597. [Abstract] [Full Text]
|
|
|
|
|
|
A. Hossain, S. Tsuchiya, M. Minegishi, M. Osada, S. Ikawa, F.-a. Tezuka, M. Kaji, T. Konno, M. Watanabe, and H. Kikuchi The Ah Receptor Is Not Involved in 2,3,7,8-Tetrachlorodibenzo- p-dioxin-mediated Apoptosis in Human Leukemic T Cell Lines J. Biol. Chem., July 31, 1998; 273(31): 19853 - 19858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ashok, C. Turner, and T. G. Wilson Insect juvenile hormone resistance gene homology with the bHLH-PAS family of transcriptional regulators PNAS, March 17, 1998; 95(6): 2761 - 2766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Smith, B. Clothier, S. Robinson, M. J. Scullion, P. Carthew, R. Edwards, J. Luo, C. K. Lim, and M. Toledano Interaction between Iron Metabolism and 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Mice with Variants of the Ahr Gene: A Hepatic Oxidative Mechanism Mol. Pharmacol., January 1, 1998; 53(1): 52 - 61. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Cohen and L. Ellwein Cell proliferation in carcinogenesis Science, August 31, 1990; 249(4972): 1007 - 1011. [Abstract] [PDF]
|
|
|
|
|
|
D. McConkey, P Hartzell, S. Duddy, H Hakansson, and S Orrenius 2,3,7,8-Tetrachlorodibenzo-p-dioxin kills immature thymocytes by Ca2+-mediated endonuclease activation Science, October 14, 1988; 242(4876): 256 - 259. [Abstract] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
